Provided by Tiger Trade Technology Pte. Ltd.

Doximity, Inc.

25.55
+0.32001.27%
Post-market: 25.560.0100+0.04%19:59 EST
Volume:2.25M
Turnover:57.54M
Market Cap:4.72B
PE:21.47
High:25.91
Open:25.05
Low:24.98
Close:25.23
52wk High:76.51
52wk Low:23.66
Shares:184.71M
Float Shares:133.13M
Volume Ratio:0.53
T/O Rate:1.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.19
EPS(LYR):1.11
ROE:23.82%
ROA:12.84%
PB:4.82
PE(LYR):23.02

Loading ...

Goldman Sachs Sticks to Their Hold Rating for Dr. Martens Plc (DOCS)

TIPRANKS
·
Nov 21, 2025

Peel Hunt Reaffirms Their Buy Rating on Dr. Martens Plc (DOCS)

TIPRANKS
·
Nov 21, 2025

Can Doximity’s (DOCS) Share Buybacks and Earnings Strength Tell Us More About Its Growth Vision?

Simply Wall St.
·
Nov 20, 2025

Jim Cramer: Don't Buy This Health Care Stock Yet, It Is 'Still Too Expensive'

Benzinga_recent_news
·
Nov 13, 2025

Dr. Martens Directors Participate in Share Incentive Plan

TIPRANKS
·
Nov 12, 2025

Dr. Martens Plc (DOCS) Receives a Hold from RBC Capital

TIPRANKS
·
Nov 12, 2025

Analysts Conflicted on These Healthcare Names: Madrigal Pharmaceuticals (MDGL), Doximity (DOCS) and Sutro Biopharma (STRO)

TIPRANKS
·
Nov 11, 2025

Doximity Is Maintained at Hold by Canaccord Genuity

Dow Jones
·
Nov 11, 2025

OpenAI considers consumer health tools in push beyond core AI offerings, Business Insider reports

Reuters
·
Nov 10, 2025

Stock Track | Doximity Plummets 14.73% as Q2 Beat Overshadowed by Disappointing Growth Outlook

Stock Track
·
Nov 08, 2025

Analysts Offer Insights on Healthcare Companies: Doximity (DOCS), Cartesian Therapeutics (RNAC) and Anixa Biosciences (ANIX)

TIPRANKS
·
Nov 07, 2025

Stock Track | Doximity Plummets 9.70% in Pre-market Following Q2 Results and Disappointing Growth Outlook

Stock Track
·
Nov 07, 2025

Stock Track | Doximity Plummets 9.70% Despite Strong Q2 Results as Growth Outlook Disappoints Investors

Stock Track
·
Nov 07, 2025

Doximity Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Nov 07, 2025

Doximity price target lowered to $70 from $81 at Evercore ISI

TIPRANKS
·
Nov 07, 2025

Stock Track | Doximity Plunges 6.22% Pre-Market Despite Strong Q2 Results as Growth Outlook Disappoints

Stock Track
·
Nov 07, 2025

Doximity Shares Down 8.9% Premarket After Q2 Results

THOMSON REUTERS
·
Nov 07, 2025

Doximity Reports Strong Q2 Growth and AI Expansion

TIPRANKS
·
Nov 07, 2025

Stock Track | Doximity Plunges 8.12% After Hours Despite Strong Q2 Results as Growth Outlook Disappoints

Stock Track
·
Nov 07, 2025

Stock Track | Doximity Plunges 8% Despite Strong Q2 Results as Growth Outlook Disappoints

Stock Track
·
Nov 07, 2025